Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CREBRF | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-06 |
mRNA | METRNL | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
mRNA | CYTH3 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
mRNA | RPF1 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
mRNA | ABHD12 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
mRNA | CCNF | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | TIGD6 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |
mRNA | NFS1 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-06 |
mRNA | WDR33 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | FAM9A | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |